Latest filing published 30 Oct 2024 for Monopar Therapeutics, €23k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +491.4%Entry US$14.57 · Close at T+365 US$86.16
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Karthik Radhakrishnan: trading record in brief
Karthik Radhakrishnan is a declared insider at 2 companies; the most frequent names are Acer Therapeutics Inc. and Monopar Therapeutics. In total, 5 filings cover trades dated from 8 August 2013 to 28 October 2024.
No open-market sale appears; the market trades are 3 purchases worth €89k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 share grant and 1 option exercise. 2024 to date brings 1 purchase and no sales.
The median purchase comes to €23k.
The latest filing, published on 30 October 2024, reports an open-market purchase of €23k in Monopar Therapeutics. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Karthik Radhakrishnan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,550 shares@ US$16.25100.0% of flowCommon StockSEC:0001437749-24-032626:0Canonical exit: 26 Jan 2025 (T+90)
- 50,000 sharesCommon StockSEC:0001354488-15-001661:0
- 16,659 shares0Common StockSEC:0001140361-14-010969:0
- 8,000 shares@ US$1.70Common StockSEC:0001140361-13-046709:0Canonical exit: 18 Mar 2014 (T+90)
- 50,000 shares@ US$1.50Common StockSEC:0001140361-13-031305:0Canonical exit: 6 Nov 2013 (T+90)
5 of 5 declarations
